Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 403

1.

Evasion of Immune Surveillance in Low Oxygen Environments Enhances Candida albicans Virulence.

Lopes JP, Stylianou M, Backman E, Holmberg S, Jass J, Claesson R, Urban CF.

MBio. 2018 Nov 6;9(6). pii: e02120-18. doi: 10.1128/mBio.02120-18.

2.

Distinct transcriptional response of Caenorhabditis elegans to different exposure routes of perfluorooctane sulfonic acid.

Stylianou M, Björnsdotter MK, Olsson PE, Ericson Jogsten I, Jass J.

Environ Res. 2018 Oct 18;168:406-413. doi: 10.1016/j.envres.2018.10.019. [Epub ahead of print]

PMID:
30388497
3.

Metal contaminated soil leachates from an art glass factory elicit stress response, alter fatty acid metabolism and reduce lifespan in Caenorhabditis elegans.

Rai N, Sjöberg V, Forsberg G, Karlsson S, Olsson PE, Jass J.

Sci Total Environ. 2018 Oct 6;651(Pt 2):2218-2227. doi: 10.1016/j.scitotenv.2018.10.067. [Epub ahead of print]

PMID:
30326454
4.

Related carbapenemase-producing Klebsiella isolates detected in both a hospital and associated aquatic environment in Sweden.

Khan FA, Hellmark B, Ehricht R, Söderquist B, Jass J.

Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2241-2251. doi: 10.1007/s10096-018-3365-9. Epub 2018 Aug 31.

PMID:
30171482
5.

Development of Escherichia coli-based gene expression profiling of sewage sludge leachates.

Goswami M, Khan FA, Ibrisevic A, Olsson PE, Jass J.

J Appl Microbiol. 2018 Nov;125(5):1502-1517. doi: 10.1111/jam.14028. Epub 2018 Jul 24.

PMID:
29928772
6.

Di(2-ethylhexyl) phthalate and diethyl phthalate disrupt lipid metabolism, reduce fecundity and shortens lifespan of Caenorhabditis elegans.

Pradhan A, Olsson PE, Jass J.

Chemosphere. 2018 Jan;190:375-382. doi: 10.1016/j.chemosphere.2017.09.123. Epub 2017 Sep 28.

PMID:
29020644
7.

Transcriptional responses of zebrafish to complex metal mixtures in laboratory studies overestimates the responses observed with environmental water.

Pradhan A, Ivarsson P, Ragnvaldsson D, Berg H, Jass J, Olsson PE.

Sci Total Environ. 2017 Apr 15;584-585:1138-1146. doi: 10.1016/j.scitotenv.2017.01.174. Epub 2017 Jan 31.

PMID:
28159303
8.

Insights into the function of FhaA, a cell division-associated protein in mycobacteria.

Viswanathan G, Yadav S, Joshi SV, Raghunand TR, Jass J.

FEMS Microbiol Lett. 2017 Jan 1;364(2). doi: 10.1093/femsle/fnw294.

PMID:
28013239
9.

Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli.

Goswami M, Subramanian M, Kumar R, Jass J, Jawali N.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4369-74. doi: 10.1128/AAC.00414-16. Print 2016 Jul.

10.

Data in support of the comparative genome analysis of Lysinibacillus B1-CDA, a bacterium that accumulates arsenics.

Rahman A, Nahar N, Nawani NN, Jass J, Ghosh S, Olsson B, Mandal A.

Data Brief. 2015 Oct 9;5:579-85. doi: 10.1016/j.dib.2015.09.040. eCollection 2015 Dec.

11.

Complete Genome Sequence of Lysinibacillus sphaericus B1-CDA, a Bacterium That Accumulates Arsenic.

Rahman A, Nahar N, Jass J, Olsson B, Mandal A.

Genome Announc. 2016 Jan 21;4(1). pii: e00999-15. doi: 10.1128/genomeA.00999-15.

12.

Comparative genome analysis of Lysinibacillus B1-CDA, a bacterium that accumulates arsenics.

Rahman A, Nahar N, Nawani NN, Jass J, Ghosh S, Olsson B, Mandal A.

Genomics. 2015 Dec;106(6):384-92. doi: 10.1016/j.ygeno.2015.09.006. Epub 2015 Sep 24.

13.

Bioremediation of hexavalent chromium (VI) by a soil-borne bacterium, Enterobacter cloacae B2-DHA.

Rahman A, Nahar N, Nawani NN, Jass J, Hossain K, Saud ZA, Saha AK, Ghosh S, Olsson B, Mandal A.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2015;50(11):1136-47. doi: 10.1080/10934529.2015.1047670.

PMID:
26191988
14.

Comparative Analysis of Stress Induced Gene Expression in Caenorhabditis elegans following Exposure to Environmental and Lab Reconstituted Complex Metal Mixture.

Kumar R, Pradhan A, Khan FA, Lindström P, Ragnvaldsson D, Ivarsson P, Olsson PE, Jass J.

PLoS One. 2015 Jul 13;10(7):e0132896. doi: 10.1371/journal.pone.0132896. eCollection 2015.

15.

Reference gene selection for qPCR is dependent on cell type rather than treatment in colonic and vaginal human epithelial cell lines.

Jacobsen AV, Yemaneab BT, Jass J, Scherbak N.

PLoS One. 2014 Dec 19;9(12):e115592. doi: 10.1371/journal.pone.0115592. eCollection 2014.

16.

Hospitals' internal accountability.

Kraetschmer N, Jass J, Woodman C, Koo I, Kromm SK, Deber RB.

Healthc Policy. 2014 Sep;10(Spec issue):36-44.

17.

Isolation and characterization of a Lysinibacillus strain B1-CDA showing potential for bioremediation of arsenics from contaminated water.

Rahman A, Nahar N, Nawani NN, Jass J, Desale P, Kapadnis BP, Hossain K, Saha AK, Ghosh S, Olsson B, Mandal A.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2014;49(12):1349-60. doi: 10.1080/10934529.2014.928247.

PMID:
25072766
18.

Contribution of pharmaceuticals, fecal bacteria and endotoxin to the inflammatory responses to inland waters.

El Marghani A, Pradhan A, Seyoum A, Khalaf H, Ros T, Forsberg LH, Nermark T, Osterman L, Wiklund U, Ivarsson P, Jass J, Olsson PE.

Sci Total Environ. 2014 Aug 1;488-489:228-35. doi: 10.1016/j.scitotenv.2014.04.090. Epub 2014 May 13.

PMID:
24836131
19.

The role of calcium, NF-κB and NFAT in the regulation of CXCL8 and IL-6 expression in Jurkat T-cells.

Khalaf H, Jass J, Olsson PE.

Int J Biochem Mol Biol. 2013 Sep 13;4(3):150-6. eCollection 2013.

20.

Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features.

Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD.

Mod Pathol. 2013 Jun;26(6):825-34. doi: 10.1038/modpathol.2012.240. Epub 2013 Jan 25.

21.

Lactobacilli differently regulate expression and secretion of CXCL8 in urothelial cells.

Karlsson M, Jass J.

Benef Microbes. 2012 Sep;3(3):195-203. doi: 10.3920/BM2012.0011.

PMID:
22835703
22.

Substances released from probiotic Lactobacillus rhamnosus GR-1 potentiate NF-κB activity in Escherichia coli-stimulated urinary bladder cells.

Karlsson M, Scherbak N, Khalaf H, Olsson PE, Jass J.

FEMS Immunol Med Microbiol. 2012 Nov;66(2):147-56. doi: 10.1111/j.1574-695X.2012.00994.x. Epub 2012 Jun 21.

23.

Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.

Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Woodall S, Arnold J, Walker NI, Jass JR, Parry S, Young JP.

Am J Surg Pathol. 2012 Jun;36(6):876-82. doi: 10.1097/PAS.0b013e31824e133f.

24.

Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.

Walsh MD, Buchanan DD, Pearson SA, Clendenning M, Jenkins MA, Win AK, Walters RJ, Spring KJ, Nagler B, Pavluk E, Arnold ST, Goldblatt J, George J, Suthers GK, Phillips K, Hopper JL, Jass JR, Baron JA, Ahnen DJ, Thibodeau SN, Lindor N, Parry S, Walker NI, Rosty C, Young JP.

Mod Pathol. 2012 May;25(5):722-30. doi: 10.1038/modpathol.2011.209. Epub 2012 Feb 10.

25.

Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4.

Karlsson M, Scherbak N, Reid G, Jass J.

BMC Microbiol. 2012 Jan 22;12:15. doi: 10.1186/1471-2180-12-15.

26.

Optimizing community and stakeholder engagement in a merger of community health centres.

Cohen A, Fairclough L, Jass J.

Healthc Manage Forum. 2011 Winter;24(4):192-5.

PMID:
22256516
27.

Oncogenic PIK3CA mutations in colorectal cancers and polyps.

Whitehall VL, Rickman C, Bond CE, Ramsnes I, Greco SA, Umapathy A, McKeone D, Faleiro RJ, Buttenshaw RL, Worthley DL, Nayler S, Zhao ZZ, Montgomery GW, Mallitt KA, Jass JR, Matsubara N, Notohara K, Ishii T, Leggett BA.

Int J Cancer. 2012 Aug 15;131(4):813-20. doi: 10.1002/ijc.26440. Epub 2011 Nov 19.

28.

Post-synthetic modification of plant cell walls by expression of microbial hydrolases in the apoplast.

Pogorelko G, Fursova O, Lin M, Pyle E, Jass J, Zabotina OA.

Plant Mol Biol. 2011 Nov;77(4-5):433-45. doi: 10.1007/s11103-011-9822-9. Epub 2011 Sep 11.

PMID:
21910026
29.

Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.

Ishii T, Notohara K, Umapathy A, Mallitt KA, Chikuba H, Moritani Y, Tanaka N, Rosty C, Matsubara N, Jass J, Leggett B, Whitehall V.

Am J Surg Pathol. 2011 Feb;35(2):212-20. doi: 10.1097/PAS.0b013e318205df20.

PMID:
21263241
30.

Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).

Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD, Young BW, Jass JR, Rosty C, Gattas M, Pelzer E, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Parry S, Woodall S, Arnold J, Tucker K, Muir A, Drini M, Macrae F, Newcomb P, Potter JD, Pavluk E, Lindblom A, Young JP.

Fam Cancer. 2011 Jun;10(2):245-54. doi: 10.1007/s10689-010-9408-8.

31.

Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.

Khalaf H, Jass J, Olsson PE.

BMC Immunol. 2010 May 27;11:26. doi: 10.1186/1471-2172-11-26.

32.

Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study.

Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, Roberts A, Young A, Hampel H, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Chow E, Parry S, Woodall S, Tucker K, Muir A, Field M, Greening S, Gallinger S, Green J, Woods MO, Spaetgens R, de la Chapelle A, Macrae F, Walker NI, Jass JR, Young JP.

Int J Colorectal Dis. 2010 Jun;25(6):703-12. doi: 10.1007/s00384-010-0907-8. Epub 2010 Mar 6. Erratum in: Int J Colorectal Dis. 2010 Dec;25(12):1513-5.

33.

Risks of Lynch syndrome cancers for MSH6 mutation carriers.

Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH; Dutch Lynch Syndrome Study Group, Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA.

J Natl Cancer Inst. 2010 Feb 3;102(3):193-201. doi: 10.1093/jnci/djp473. Epub 2009 Dec 22.

34.
35.

Pragmatic classification of superficial neoplastic colorectal lesions.

Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G.

Gastrointest Endosc. 2009 Dec;70(6):1182-99. doi: 10.1016/j.gie.2009.09.015. Epub 2009 Oct 31. No abstract available.

PMID:
19879563
36.

Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry.

Lindor NM, Yang P, Evans I, Schowalter K, De Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B, Hopper J, Jass J, Jenkins M, Templeton A, Potter J, Newcomb PA, Lemarchand L, Grove J, Haile R, Baron J, Seminara D, Limburg P, Thibodeau SN.

Mol Genet Metab. 2010 Feb;99(2):157-9. doi: 10.1016/j.ymgme.2009.09.010. Epub 2009 Sep 27.

37.

HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.

Walsh MD, Dent OF, Young JP, Wright CM, Barker MA, Leggett BA, Bokey L, Chapuis PH, Jass JR, Macdonald GA.

Int J Cancer. 2009 Sep 1;125(5):1231-7. doi: 10.1002/ijc.24484.

38.

High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.

Chong G, Jarry J, Marcus V, Thiffault I, Winocour S, Monczak Y, Drouin R, Latreille J, Australie K, Bapat B, Gordon PH, Giguère Y, Gologan A, Galiatsatos P, Jass JR, Wong N, Zaor S, Palma L, Kasprzak L, Tischkowitz M, Foulkes WD.

Hum Mutat. 2009 Aug;30(8):E797-812. doi: 10.1002/humu.21056.

PMID:
19459153
39.

The association of tumor microsatellite instability phenotype with family history of colorectal cancer.

Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):967-75. doi: 10.1158/1055-9965.EPI-08-0878. Epub 2009 Mar 3.

40.

Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.

Walsh MD, Buchanan DD, Walters R, Roberts A, Arnold S, McKeone D, Clendenning M, Ruszkiewicz AR, Jenkins MA, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Macrae F, Drini M, Woods MO, Parry S, Jass JR, Young JP.

Fam Cancer. 2009;8(4):313-23. doi: 10.1007/s10689-009-9238-8. Epub 2009 Feb 25.

41.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC; CAPP2 Investigators.

N Engl J Med. 2008 Dec 11;359(24):2567-78. doi: 10.1056/NEJMoa0801297. Erratum in: N Engl J Med. 2009 Apr 2;360(14):1470.

42.

In vitro analysis of inflammatory responses following environmental exposure to pharmaceuticals and inland waters.

Khalaf H, Salste L, Karlsson P, Ivarsson P, Jass J, Olsson PE.

Sci Total Environ. 2009 Feb 1;407(4):1452-60. doi: 10.1016/j.scitotenv.2008.10.016. Epub 2008 Nov 26.

PMID:
19038416
43.

Nonpolypoid neoplastic lesions of the colorectal mucosa.

Kudo Se, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD.

Gastrointest Endosc. 2008 Oct;68(4 Suppl):S3-47. doi: 10.1016/j.gie.2008.07.052. Review. No abstract available.

PMID:
18805238
44.

Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.

English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1774-80. doi: 10.1158/1055-9965.EPI-08-0091.

45.

Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.

Liljegren A, Barker G, Elliott F, Bertario L, Bisgaard ML, Eccles D, Evans G, Macrae F, Maher E, Lindblom A, Rotstein S, Nilsson B, Mecklin JP, Möslein G, Jass J, Fodde R, Mathers J, Burn J, Bishop DT.

J Clin Oncol. 2008 Jul 10;26(20):3434-9. doi: 10.1200/JCO.2007.13.2795.

46.

Colorectal polyposes: from phenotype to diagnosis.

Jass JR.

Pathol Res Pract. 2008;204(7):431-47. doi: 10.1016/j.prp.2008.03.008. Epub 2008 Jun 9. Review.

PMID:
18541388
47.

MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells.

Baker K, Foulkes WD, Jass JR.

Cancer Immunol Immunother. 2009 Jan;58(1):135-44. doi: 10.1007/s00262-008-0534-1. Epub 2008 May 17.

PMID:
18488217
48.

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.

Zlobec I, Terracciano L, Tornillo L, Günthert U, Vuong T, Jass JR, Lugli A.

Gut. 2008 Oct;57(10):1413-9. doi: 10.1136/gut.2007.141192. Epub 2008 Apr 24.

PMID:
18436576
49.

Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management.

East JE, Saunders BP, Jass JR.

Gastroenterol Clin North Am. 2008 Mar;37(1):25-46, v. doi: 10.1016/j.gtc.2007.12.014. Review.

PMID:
18313538
50.

Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.

Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, Bond CE, Simms LA, Pike T, Young JP, Jass JR, Spring KJ, Leggett BA, Whitehall VL.

Genes Chromosomes Cancer. 2008 Jun;47(6):449-60. doi: 10.1002/gcc.20552.

PMID:
18311777

Supplemental Content

Support Center